Acorn Bioventures

Investor type Venture Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 11
Average round size
info
The average size of a deal this fund participated in
$70M
Portfolio companies 10
Rounds per year 2.20
Lead investments 2
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.09
Exits 5
Key employees Soon

Areas of investment

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Biopharma

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Acorn Bioventures:
Typical Co-investors
Acorn Bioventures is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Acorn Bioventures:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
1818 Venture Capital Guernsey, Guernsey, NA - Guernsey
Acuity Brands Atlanta, Georgia, United States
AI Fund California, Palo Alto, United States
Ascend Capital Partners -
Autobot Capital Partners Beijing, Beijing, China
Bellwether -
Chariot Gold Limited -
Checketts Partners Investment Fund -
Cheval Holdings -
Clear Future Herzliya, Israel, Tel Aviv
Commodore Capital New York, New York, United States
GeneScience Pharmaceuticals -
Hermann Companies Arkansas, Paragould, United States
HumanCo New York, New York, United States
Koch Equity Development Kansas, United States, Wichita
Moneta VC Israel, Ramat Gan, Tel Aviv
National Building and Marketing Ar Riyad, Riyadh, Saudi Arabia
Orgain California, Irvine, United States
Technologies SAS -
Yiguo Group Changning, China, Shanghai

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Neuron23

Health Care
Medical
$100M30 Mar 2022 San Francisco, California, United States

ONK Therapeutics

Health Care
Therapeutics
$21M06 Jan 2022 Galway City, County Galway, Ireland

Renovacor

Biotechnology
$30M03 Sep 2021 Philadelphia, Pennsylvania, United States

Eliem Therapeutics

Biotechnology
Health Care
Pharmaceutical
$60M24 May 2021 Washington, United States

OnKure

Biotechnology
Life Science
Therapeutics
$56M04 Mar 2021 Boulder, Colorado, United States

Gemini Therapeutics

Biopharma
Biotechnology
Health Diagnostics
$95M08 Feb 2021 Cambridge, Massachusetts, United States

Aileron Therapeutics

Biopharma
Biotechnology
Therapeutics
$35M06 Jan 2021 Cambridge, Massachusetts, United States

Health Care
Medical
$80M16 Dec 2020 San Francisco, California, United States

Verona Pharma

Biotechnology
Pharmaceutical
Therapeutics
$200M17 Jul 2020 London, England, United Kingdom

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Acorn Bioventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: